BGM Group Ltd (BGM)

• Market cap: $229M
• 1 day: -6.56%
• 5 days: -67.43%
• 1 month: -70.62%
• 3 months: -87.61%
• 6 months: -86.08%
• Year to date: -68.16%
• 1 year: -90%
• 5 years: -96.8%
• 10 years: -97.72%
• Sector: Healthcare
• Industry: Drug Manufacturers - Specialty & Generic

About: BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.

Employees: 323